{"id":"https://openalex.org/W4200423378","doi":"https://doi.org/10.1016/j.euroneuro.2021.10.288","title":"P.0305 Investigating the effects of CYP2C19*2 genetic polymorphisms on the efficacy and safety of diazepam in patients with alcohol withdrawal syndrome","display_name":"P.0305 Investigating the effects of CYP2C19*2 genetic polymorphisms on the efficacy and safety of diazepam in patients with alcohol withdrawal syndrome","alternate_titles":[],"publication_year":2021,"publication_date":"2021-12-01","ids":{"openalex":"https://openalex.org/W4200423378","doi":"https://doi.org/10.1016/j.euroneuro.2021.10.288"},"language":"en","primary_location":{"id":"doi:10.1016/j.euroneuro.2021.10.288","doi":"https://doi.org/10.1016/j.euroneuro.2021.10.288","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.euroneuro.2021.10.288","pdf_url":null,"source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4200423378"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016187949","display_name":"\u0412.\u042e. \u0421\u043a\u0440\u044f\u0431\u0438\u043d","orcid":"https://orcid.org/0000-0002-4942-8556","observed_orcids":["https://orcid.org/0000-0002-4942-8556"]},"institutions":[{"id":"https://openalex.org/I4405260047","display_name":"Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare","ror":"https://ror.org/0352ndv59","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4405260047"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"V. Skriabin","raw_affiliation_strings":["Moscow Research and Practical Center on Addictions, Department No.2, Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moscow Research and Practical Center on Addictions, Department No.2, Moscow, Russian Federation","institution_ids":["https://openalex.org/I4405260047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029908525","display_name":"M. S. Zastrozhin","orcid":"https://orcid.org/0000-0003-0607-4812","observed_orcids":["https://orcid.org/0000-0003-0607-4812"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Zastrozhin","raw_affiliation_strings":["Moscow Research and Practical Center on Addictions, Genetic Lab, Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moscow Research and Practical Center on Addictions, Genetic Lab, Moscow, Russian Federation","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091837013","display_name":"Dmitry Alekseevich Sychev","orcid":"https://orcid.org/0000-0002-4496-3680","observed_orcids":["https://orcid.org/0000-0002-4496-3680"]},"institutions":[{"id":"https://openalex.org/I4210108300","display_name":"Russian Medical Academy of Continuous Professional Education","ror":"https://ror.org/01t6bjk79","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210108300","https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"D. Sychev","raw_affiliation_strings":["Russian Medical Academy for Continuous Professional Education, Rector, Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Russian Medical Academy for Continuous Professional Education, Rector, Moscow, Russian Federation","institution_ids":["https://openalex.org/I4210108300"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058317898","display_name":"Evgeny Alekseevich Bryun","orcid":"https://orcid.org/0000-0002-8366-9732","observed_orcids":["https://orcid.org/0000-0002-8366-9732"]},"institutions":[{"id":"https://openalex.org/I4405260047","display_name":"Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare","ror":"https://ror.org/0352ndv59","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4405260047"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"E. Bryun","raw_affiliation_strings":["Moscow Research and Practical Center on Addictions, President, Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moscow Research and Practical Center on Addictions, President, Moscow, Russian Federation","institution_ids":["https://openalex.org/I4405260047"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"53","issue":null,"first_page":"S221","last_page":"S221"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.5976999998092651,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.5976999998092651,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10436","display_name":"Anesthesia and Sedative Agents","score":0.32519999146461487,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12494","display_name":"Alcoholism and Thiamine Deficiency","score":0.01850000023841858,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alcohol-withdrawal-syndrome","display_name":"alcohol withdrawal","score":0.753000020980835},{"id":"https://openalex.org/keywords/diazepam","display_name":"diazepam","score":0.9290000200271606},{"id":"https://openalex.org/keywords/dexmedetomidine","display_name":"dexmedetomidine","score":1.0},{"id":"https://openalex.org/keywords/cyp2c19-2-polymorphism","display_name":"CYP2C19*2 polymorphism","score":0.8889999985694885},{"id":"https://openalex.org/keywords/alcohol-withdrawal-treatment","display_name":"alcohol withdrawal treatment","score":0.550000011920929},{"id":"https://openalex.org/keywords/hemodynamic-effects","display_name":"hemodynamic effects","score":0.7459999918937683},{"id":"https://openalex.org/keywords/heart-rate","display_name":"heart rate","score":0.9769999980926514},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.9319999814033508},{"id":"https://openalex.org/keywords/sedation","display_name":"sedation","score":0.6389999985694885},{"id":"https://openalex.org/keywords/traumatic-brain-injury","display_name":"traumatic brain injury","score":0.7730000019073486},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.6899999976158142},{"id":"https://openalex.org/keywords/alpha-2-adrenergic-agonists","display_name":"alpha-2 adrenergic agonists","score":0.7620000243186951},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.675000011920929},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.7730000019073486},{"id":"https://openalex.org/keywords/merida","display_name":"M\u00e9rida","score":0.6850000023841858}],"concepts":[{"id":"https://openalex.org/C2781302539","wikidata":"https://www.wikidata.org/wiki/Q412133","display_name":"Dexmedetomidine","level":3,"score":0.78818678855896},{"id":"https://openalex.org/C2776175493","wikidata":"https://www.wikidata.org/wiki/Q210402","display_name":"Diazepam","level":2,"score":0.7829071879386902},{"id":"https://openalex.org/C2776814716","wikidata":"https://www.wikidata.org/wiki/Q574801","display_name":"Sedation","level":2,"score":0.7177713513374329},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6811288595199585},{"id":"https://openalex.org/C2780873584","wikidata":"https://www.wikidata.org/wiki/Q2914873","display_name":"Alcohol withdrawal syndrome","level":3,"score":0.6299408674240112},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.6124382019042969},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4708133637905121},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.46850186586380005},{"id":"https://openalex.org/C65409693","wikidata":"https://www.wikidata.org/wiki/Q425265","display_name":"Statistical significance","level":2,"score":0.43966346979141235},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.42895883321762085},{"id":"https://openalex.org/C2781066024","wikidata":"https://www.wikidata.org/wiki/Q156","display_name":"Alcohol","level":2,"score":0.2862781882286072},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27662527561187744},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.euroneuro.2021.10.288","doi":"https://doi.org/10.1016/j.euroneuro.2021.10.288","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.euroneuro.2021.10.288","pdf_url":null,"source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4226321370","https://openalex.org/W4241069007","https://openalex.org/W4210547796","https://openalex.org/W1913553265","https://openalex.org/W2738289393","https://openalex.org/W2334885094","https://openalex.org/W2118010630","https://openalex.org/W2073145166","https://openalex.org/W2330744961","https://openalex.org/W2204514959"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4200423378","counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2021-12-31T00:00:00"}
